FDA issues a final guidance on coordination of development and review of antimicrobial drugs with antimicrobial susceptibility tests.
Management researchers suggest a more flexible approach to FDA drug review and evaluation.
Edwards Lifesciences says it is making a one-time payment of $180 million to Boston Scientific as part of a settlement of all outstanding patent dispu...
FDA approves an expanded indication for Sanofis Adocel as a repeat vaccination delivered eight or more years after the initial vaccination to help pro...
Eisai and Purdue Pharma submit an NDA for lemborexant for treating insomnia.
FDA issues a draft guidance on amendments and requests for final approval to tentatively approved ANDAs.
FDA approves a Teva Pharmaceuticals ANDA for the first generic version of Lundbecks Sabril (vigabatrin) 500 mg tablets for treating complex partial se...
FDA issues a revised draft guidance on common issues in drug development for rare diseases.